Accessed:

Brivaracetam

2 of 2 defined stereocentres

Wikipedia

Structural identifiers

Names and synonyms

(2S)-2-[(4R)-2-Oxo-4-propyl-1-pyrrolidinyl]butanamid

[German]

[ACD/IUPAC Name]

(2S)-2-[(4R)-2-Oxo-4-propyl-1-pyrrolidinyl]butanamide

[ACD/IUPAC Name]

(2S)-2-[(4R)-2-Oxo-4-propyl-1-pyrrolidinyl]butanamide

[French]

[ACD/IUPAC Name]

1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-

[ACD/Index Name]

357336-20-0

[RN]

Brivaracetam

[INN] [USAN]

Briviact

[Trade name]

Rikelta

[Trade name]

U863JGG2IA

[UNII]

(2S)-2-[(4R)-2-keto-4-propyl-pyrrolidin-1-yl]butyramide

(2S)-2-[(4R)-2-oxo-4-propyl-pyrrolidin-1-yl]butanamide

(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide

(S)-2-((R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide

1202896-51-2

[RN]

2(S)-[2-Oxo-4(R)-propylpyrrolidin-1-yl]butyramide

2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide

97%

brivaracetam-d7

Briviact®

CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1

compound 83α

MFCD25976668

[MDL number]

UCB 34714;UCB34714;UCB-34714

Database IDs